The Eugene Braunwald Academic Mentorship Award commemorates the legacy of Dr. Eugene Braunwald, a titan in cardiology known for his transformative contributions to cardiovascular science and exemplary guidance of emerging researchers. The award pays tribute to those who have demonstrated unwavering dedication to educating and inspiring upcoming generations of faculty, clinicians, and scientists, thereby ensuring a continuum of excellence in cardiovascular research and patient care. Dr. Benjamin’s receipt of this award is a testament to her steadfast commitment to cultivating talent and advancing the field through mentorship.

Dr. Benjamin holds the distinguished position of Jay and Louise Coffman Professor in Vascular Medicine at the Boston University Chobanian and Avedisian School of Medicine, along with professorship in epidemiology at the Boston University School of Public Health. Her career trajectory is marked by the development of comprehensive faculty development programs aimed at early- and mid-career clinicians and investigators, with a nuanced focus on fostering diversity within the research community. These programs integrate rigorous scientific training with leadership development, equipping mentees to tackle complex cardiovascular challenges with innovative approaches.

An integral component of Dr. Benjamin’s mentorship portfolio includes directing multi-institutional fellowships funded by the American Heart Association and the National Institutes of Health (NIH). Notably, she oversees an international fellowship dedicated to the genetics of atrial fibrillation—a complex cardiac arrhythmia linked to significant morbidity worldwide. Her research portfolio, continuously supported by NIH grants since 1998, encompasses pioneering work on atrial fibrillation pathogenesis, mobile health technologies for chronic disease management, systemic inflammation, and chronic pain mechanisms. Such sustained funding and research productivity underscore her status as a leader in cardiovascular medicine.

The fruits of Dr. Benjamin’s mentorship are evident in the trailblazing achievements of her mentees, many of whom have secured NIH Career Development Awards, paving their way to independent research careers. This outcome reflects her ability to instill rigorous scientific inquiry, ethical research practices, and a collaborative spirit. Furthermore, her leadership roles within the American Heart Association have amplified support structures for early-career scientists, including chairing influential councils and committees that shape strategic initiatives fostering young investigators. Her work exemplifies how mentorship directly enriches scientific discovery and clinical advancement.

Visionary and compassionate, Dr. Benjamin has received numerous accolades that honor both her scientific acumen and her dedication to mentorship. Among these are the Distinguished Scientist Award, Gold Heart Award, Population Research Prize, and the Paul Dudley White Award—each reflecting different facets of excellence in research and education. Furthermore, she has been recognized specifically for her efforts to promote equity and inclusion in cardiovascular science, including awards that celebrate her support for women and underrepresented groups in medicine. This dual legacy of scientific innovation and advocacy positions her as a transformative figure.

Dr. Stacey E. Rosen, M.D., FAHA, the 2025-2026 American Heart Association volunteer president, eloquently recognized Dr. Benjamin’s contributions, underscoring her role as both an outstanding scientist and a powerful advocate for developing the next generation of cardiovascular investigators. Dr. Benjamin’s dedication to nurturing diverse talent resonates with the American Heart Association’s commitment to equity and health advancement, thereby ensuring that the future of cardiovascular science is inclusive and dynamic.

Dr. Benjamin’s scientific achievements are both broad and deep. With over 800 peer-reviewed publications to her credit, her research spans the epidemiology, genetics, clinical outcomes, and prognostic factors of multiple cardiovascular diseases. As a leading investigator with the Framingham Heart Study—the landmark longitudinal project that uncovered key risk factors for heart disease—her work continues to elucidate complex cardiovascular phenotypes. Her research contributions have also helped shape national clinical guidelines, including significant input on the 2023 ACC/AHA/ACCP/HRS guidelines for managing atrial fibrillation.

Educationally grounded with an MD from Case Western Reserve University School of Medicine and advanced epidemiological training at Harvard T.H. Chan School of Public Health, Dr. Benjamin exemplifies the integration of clinical insight and rigorous scientific methodology. Her receipt of an honorary Doctor of Medical Science degree from Denmark’s Aalborg University further acknowledges her international impact on cardiovascular research and public health scholarship. Such recognition highlights her global influence beyond academia into the realms of international health policy and research collaboration.

Throughout her career, Dr. Benjamin has pioneered innovative research collaborations and workshops, co-chairing influential initiatives like the 2008 National Heart, Lung, and Blood Institute’s atrial fibrillation prevention workshop. These platforms have synthesized cutting-edge knowledge on arrhythmia prevention and management, shaping research agendas and clinical practices worldwide. Her hands-on mentorship in these projects ensures that emerging scientists are embedded within high-impact clinical research, fostering an ecosystem of translational medicine.

Moreover, Dr. Benjamin’s mentorship transcends formal institutional boundaries. She has guided hundreds of colleagues informally, impacting careers across the globe. Many of these relationships have fostered successful grant awards and faculty appointments, amplifying the scope of cardiovascular research and clinical innovation. Her mentorship philosophy emphasizes not only scientific rigor but also the cultivation of leadership and resilience—qualities critical for navigating the evolving landscape of medical research.

As the cardiovascular research community honors Dr. Benjamin with the Eugene Braunwald Academic Mentorship Award, her career stands as a beacon illustrating the immense value of mentorship in advancing science and medicine. This accolade perpetuates Dr. Braunwald’s enduring legacy, signifying the essential interplay between research excellence and nurturing future leaders. The profound gratitude expressed by Dr. Benjamin towards her mentees encapsulates the symbiotic nature of mentorship, which is instrumental in shaping the trajectory of cardiovascular health and healing in coming generations.

Subject of Research: Cardiovascular medicine, academic mentorship, atrial fibrillation genetics, epidemiology, and clinical outcomes.

Article Title: Dr. Emelia J. Benjamin to Receive 2025 Eugene Braunwald Academic Mentorship Award for Pioneering Contributions to Cardiovascular Science and Mentorship.

News Publication Date: October 6, 2025.

Web References:
– American Heart Association news release: https://newsroom.heart.org/news/boston-university-professor-to-receive-2025-eugene-braunwald-academic-mentorship-award?preview=a4ff3badc467455c4041869ceb8dd3a0
– Follow updates on X: https://x.com/HeartNews

Keywords: Cardiology, cardiovascular disorders, heart disease, atrial fibrillation, academic mentorship, vascular medicine, epidemiology, NIH-funded research, cardiovascular genetics, clinical outcomes, scientific mentorship, diversity in medicine.

The Endocrine Society, a leading authority in hormone research and clinical practice, has announced the appointment of Dr. Nanette Santoro as its President-Elect for the term 2026-2027. Dr. Santoro, who has dedicated over a decade to her role as E. Stewart Taylor Chair of Obstetrics & Gynecology at the University of Colorado School of Medicine, will begin her leadership term in July 2025. She is recognized as an influential figure in the field, focusing her research primarily on menopause, both premature and age-appropriate.

Dr. Santoro’s extensive experience within the society includes holding the position of Vice President of Clinical Science, and she has made substantial contributions through authorship on key clinical practice guidelines aimed at improving women’s reproductive health. Her passion for mentorship was recognized in 2016 when she received the Endocrine Society’s Laureate Award for Outstanding Mentorship, underscoring her commitment to nurturing the next generation of scientists and physicians in endocrinology.

In addition to Dr. Santoro’s election, the Endocrine Society has named four influential figures to its Board of Directors, set to commence their tenure in July 2025. Each of these individuals brings a wealth of experience and dedication to advancing the field. Dr. Cherié Butts, from Biogen, combines her expertise in neuroendocrine regulation with a strong commitment to diversity and inclusion in biomedical research. Her prior experience at the U.S. Food and Drug Administration adds a robust regulatory perspective to the board.

Representing the realm of diabetes and health disparities, Dr. Leonor Corsino from Duke University brings a long-standing commitment to addressing the unique health challenges faced by Hispanic and Latino populations. Her research endeavors align with the goals of the Endocrine Society to promote health equity in endocrine-related conditions. Corsino’s previous roles on various society committees highlight her active engagement in promoting inclusivity and comprehensive care practices.

Dr. Patricia Morris, from The Rockefeller University, is another prominent voice selected for the board. Her dual role as a scientist and health policy advisor enhances the society’s focus on integrating research with actionable health strategies. Morris is known for her pioneering work in RNA molecular biology, contributing her substantial insight into the intersection of biotechnology and endocrine health, critical in shaping future research directions.

Lastly, Dr. Heather Patisaul from the National Institutes of Health (NIH) brings her expertise in environmental health and toxicity studies related to endocrine-disrupting chemicals. The prominence of her research underscores the increasing recognition of environmental factors on hormone-related health issues. With numerous leadership roles within the society, Patisaul is well-placed to guide conversations around the implications of environmental health in endocrinology.

The newly elected board members signify a concerted effort by the Endocrine Society to ensure diverse representation and expertise in its leadership. This is especially essential as the society addresses pressing health concerns, including diabetes, obesity, hormone-related cancers, and infertility. The upcoming Board members will commence their three-year terms after the annual meeting, ENDO 2025, scheduled for July 12-15, 2025, in San Francisco, California.

The Endocrine Society, recognized as the oldest and largest organization dedicated to hormone research, boasts a membership exceeding 18,000 globally. This vibrant community includes not only scientists and physicians but also educators and students committed to advancing the field of endocrinology. The society’s commitment to fostering interdisciplinary approaches ensures that it remains at the forefront of addressing hormonal health issues.

As the society prepares for transitions in leadership, its focus remains steadfast in navigating the evolving landscape of endocrine research and clinical practice. From diabetes management to advancing women’s health, the Endocrine Society’s initiatives will be instrumental in tackling the significant health challenges faced by communities worldwide. The newly elected leaders are expected to advocate for innovative research, engage in public discourse on health policy, and foster partnerships aimed at translating scientific advances into improved patient care.

The announcement not only heralds a new era of leadership within the Endocrine Society but stands as a testament to the organization’s ongoing commitment to excellence in endocrine science and clinical care. As health concerns continue to evolve globally, the impact of these leaders’ work will undoubtedly resonate across various communities. Their leadership and dedication will help elevate the society’s mission, pushing the boundaries of what is possible in the field of endocrinology.

Moving forward, the Endocrine Society’s collective endeavor to integrate research, clinical practice, and advocacy will foster innovative solutions to hormone-related health challenges. This strategic direction is anticipated to enhance the society’s influence and expand its role as a leader in promoting hormone health tailored for diverse population needs.

In conclusion, the Endocrine Society stands resolute in facing the dynamic challenges in health caused by hormonal issues. With the combination of experienced leadership and fresh perspectives, the society is positioned to make significant strides in addressing vital health concerns that intersect with hormones, ultimately transforming patient care and improving health outcomes across the globe.

Subject of Research: Hormonal health and endocrine conditions
Article Title: Endocrine Society Elects New Leadership for 2026-2027
News Publication Date: October 2023
Web References: N/A
References: N/A
Image Credits: N/A

Keywords: Endocrinology, Hormone Research, Women’s Health, Diversity, Health Disparities, Environmental Health, Diabetes, Mentorship, Executive Leadership, Clinical Practice